Table 1.

Characteristics of NAFLD, by LLA Use, NHANES III (1988‐1994)

Characteristics	All (n = 2,566)	No Medication Use (n = 2,450)	LLA Use
			Other Use (n = 81)	Statin Use (n = 35)	All (n = 116)
Age, SEM	47.78 (0.56)	47.18 (0.59)	58.09 (0.77)*	56.89 (2.31)*	57.68 (0.99)*
Age, years
20‐44	45.81 (2.06)	47.66 (2.16)	11.61 (6.25)	22.57 (12.35)	15.30 (5.50)*
45‐54	20.07 (1.18)	19.77 (1.29)	29.03 (6.20)	17.18 (7.60)	25.04 (4.72)
55‐64	18.62 (1.37)	17.63 (1.41)	29.72 (6.22)*	45.63 (10.19)*	35.07 (5.40)*
65‐74	15.50 (0.96)	14.95 (0.98)	29.64 (6.02)*	14.63 (5.24)†	24.58 (4.47)*
Male	52.76 (1.29)	52.46 (1.33)	53.74 (6.92)	65.48 (9.52)	57.69 (5.46)
Race
non‐Hispanic white	75.36 (1.76)	74.42 (1.82)	90.15 (3.04)*	92.46 (3.22)*	90.93 (2.39)*
non‐Hispanic black	8.67 (0.83)	8.88 (0.87)	5.72 (2.27)	4.41 (2.42)	5.28 (1.77)
Mexican American	7.64 (0.81)	7.93 (0.85)	3.10 (1.18)*	2.45 (1.59)	2.88 (0.86)*
Other	8.32 (1.32)	8.77 (1.38)	1.03 (0.77)*	0.68 (0.71)*	0.91 (0.70)*
Active smoker	22.83 (1.16)	23.66 (1.25)	10.00 (3.21)*	7.61 (5.55)	9.20 (2.90)*
Comorbidities
Obese	47.57 (1.97)	47.50 (1.99)	46.45 (7.26)	52.89 (8.69)	48.62 (5.15)
DM	15.24 (0.90)	14.45 (0.99)	24.57 (5.82)	36.66 (10.79)*	28.80 (5.23)*
HL	28.12 (1.61)	24.40 (1.59)	88.84 (4.25)*	91.07 (7.10)*	89.59 (3.69)*
HTN	35.29 (1.73)	34.02 (1.72)	60.44 (7.65)*	48.32 (9.74)	56.36 (5.77)*
MS	58.08 (1.85)	56.69 (2.01)	80.77 (7.35)*	81.60 (7.50)*	81.06 (6.31)*
CKD	13.37 (1.09)	13.23 (1.13)	17.89 (4.88)	12.22 (5.12)	15.93 (3.45)
History of cancer	7.14 (0.73)	6.70 (0.72)	13.45 (5.18)	16.40 (6.24)*	14.44 (4.44)*
History of CVD	7.80 (0.72)	6.51 (0.69)	21.89 (5.72)*	43.46 (11.44)*	29.16 (5.36)*
Overall mortality, %	25.49 (1.51)	24.29 (1.58)	49.15 (6.69)*	38.05 (9.84)*	45.41 (5.38)*
CV mortality, %	6.12 (0.64)	5.44 (0.61)	17.92 (6.11)*	16.37 (7.54)*	17.40 (4.60)*

Note: Data are presented as the weighted percentage/SEM.

*P < 0.05 compared with no medication use.

†P < 0.05 compared with other medication use.